The activity is determined by the dose dependent proliferation of FDC-P1 cells and is typically 8.39 ng/ml corresponding to a specific activity of 1.2x105U/mg..

Pureté

>95% as determined by SDS-PAGE.

Forme du produit

Lyophilized

Concentration

Reconstitution dependent.

Formulation

Lyophilized from a solution containing 0.1% TFA.

Stockage

Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Synonymes

C11orf43, FLJ22066, FLJ44734, GRDF, IGF 2, IGF II, IGF-II, IGF2_HUMAN, IGFII, INSIGF, Insulin like Growth Factor 2, insulin like growth factor 2 (somatomedin A), Insulin like growth factor II, Insulin like growth factor II precursor, Insulin like growth factor type 2, pp9974, Preptin, putative insulin like growth factor II associated protein, Somatomedin A, Somatomedin-A, T3M 11 derived growth factor

Avertissement

Ce produit est uniquement destiné à la recherche. Il n'est pas destiné à un usage diagnostique ou thérapeutique.